Table 2 Number of chemotherapy cycles received by each patient in the 5FU/LV maintenance group during treatment course and duration of treatment pause.
From: Feasibility of alternating induction and maintenance chemotherapy in pancreatic cancer
Patient | Induction FOLFIRINOX | Induction FOLFOX | Maintenance 5FU/LV | Treatment pause (weeks) | Re-induction FOLFIRINOX | Re-induction FOLFOX |
|---|---|---|---|---|---|---|
1 | 1 | 9 | 5 | — | — | 2 |
2 | 2 | 3 | 7 | — | — | 6 |
3 | 3 | 2 | 3 | — | — | 4 |
4 | 3 | 5 | 7 | — | — | — |
5 | 4 | 2 | 2 | — | — | — |
6 | 5 | 5 | 13 | — | 1 | — |
7 | 5 | — | 4 | 8.0 | 7 | — |
8 | 5 | — | 20 | 25.9 | 5 | — |
9 | 6 | — | 8 | 16.9 | 4 | — |
10 | 6 | — | 6 | — | — | 4 |
11 | 8 | — | 12 | — | 5 | — |
12 | 12 | — | 4 | — | 6 | — |
13 | 13 | — | 6 | 42.1 | — | 3 |
